Reevaluation of kidney-bone granule after marketing in the treatment of osteoarthritis.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031601

Enrollment

Unknown

Registered

2020-04-05

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Case series:Shen-Gu granule

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria of osteoarthritis.

Exclusion criteria

Exclusion criteria: (1) patients with concurrent diseases affecting joints, such as psoriasis, plum neuropathy, brown-yellow disease, acute trauma, etc.; (2) patients with cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and other serious primary diseases and mental disorders; (3) pregnant or lactating women; (4) allergic constitution or known ingredients of the drug allergy; Allergic constitution or the known ingredients of this drug allergy.

Design outcomes

Primary

Measure	Time frame
Related symptoms and signs;WOMAC questionnaire;X - ray examination of bone and joint;	—

Countries

China

Contacts

Public ContactOu YanHua

26075271@qq.com+86 13971067157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026